Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis

PURPOSE: Evocalcet is a novel oral calcimimetic drug that has demonstrated similar efficacy to cinacalcet in regulating serum parathyroid hormone (PTH), calcium, and phosphate levels, with fewer upper gastrointestinal tract-related adverse drug reactions (ADRs) in patients with secondary hyperparath...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigematsu, Takashi, Asada, Shinji, Endo, Yuichi, Kawata, Takehisa, Fukagawa, Masafumi, Akizawa, Tadao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229806/
https://www.ncbi.nlm.nih.gov/pubmed/32494184
http://dx.doi.org/10.2147/IJNRD.S243210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229806/
https://www.ncbi.nlm.nih.gov/pubmed/32494184
http://dx.doi.org/10.2147/IJNRD.S243210

Ejemplares similares